Allocations
An affiliate of KSL Capital Partners (KSL) has made a majority investment in Eden Hotels, a Dutch hotel group owned by the Dikstra family, who will retain a significant minority stake in the group, with Eden CEO Leon Dijkstra remaining in his role at the company.
RosterLab, a newly-formed rostering software company, has closed NZD150,000 in pre-seed funding from Quidnet Ventures, an early-stage venture capital fund based in New Zealand.
The NZD500,000 total round was led by Matū Fund, with participation from Quidnet Ventures and the University of Auckland Investors’ Fund. This funding will support the company’s software application development and initial product launch targeting New Zealand’s healthcare market.
RosterLab offers an automated rostering platform, based on advanced techniques developed at the University of Auckland, to a variety of high-intensity sectors, including healthcare providers.
Kingfisher Investment Advisors has led a USD30 million Series B funding round in SkySafe, an airspace security and management technology company.
New investors Gaingels, and MIT alumni investment fund Castor Ventures also participated along with previous investor Andreessen Horowitz, who led the seed and Series A investments.
To date, SkySafe has raised USD45 million in total financing, and the fresh capital will be used to help further accelerate the company’s growth through strategic hiring, R&D, and expanded production of its airspace security system for commercial adoption.
nThrive, a healthcare revenue cycle management (RCM) software-as-a-service (SaaS) platform provider, backed by Clearlake Capital Group, has completed the acquisition of TransUnion Healthcare, the healthcare data and analytics business of TransUnion.
The unified business will offer healthcare organisations one of the most complete end-to-end RCM technology solutions available, streamlining patient access for better patient and financial outcomes, and empowering customers with increased predictability and confidence in their financial performance.
Clayton, Dubilier & Rice Fund X has sold its investment in Belron, a specialist in vehicle glass repair and replacement.
Bain Capital Credit has acquired Project Frontier, which involves the sale of 95 per cent of the Mezzanine and Junior notes from a securitisation backed by a cEUR6 billion gross book value portfolio of non-performing exposures from National Bank of Greece.
Bain Capital Credit, Fortress Investment Group (Fortress) and doValue (doValue) have formed a consortium whereby funds and accounts managed by Bain Capital Credit and Fortress respectively acquired the Notes and doValue was appointed as the servicer of the securitisation.
Project Frontier is a landmark transaction, being the first large scale securitisation on a servicer-release basis, utilising the Hellenic
Stone-Goff Partners has exited its investment in Danforth Advisors (Danforth) following a private equity investment in the company by Avesi Partners, LLC.
Drawn to the company’s deep experience base and focus on the growing life sciences end market, Stone-Goff Partners invested in Danforth in 2018, alongside its founding partners.
Based outside of Boston, Danforth is the financial and operational backbone to hundreds of life science companies. Its services span wide-ranging needs, whether short or long term, including strategic advisory, accounting and operational finance support, financial planning and analysis, IPO preparation, post-public SEC compliance, clinical business operations management and strategic and
Funds advised by SK Capital Partners (SK Capital), a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has acquire a majority shareholding in SEQENS, a pharmaceutical solutions and specialty ingredients companies.
SK Capital is investing alongside several other investors including Bpifrance, the French national investment bank, Nov Santé, Mérieux Equity Partners, Ardian, Eximium and the Company’s management team.
Concurrent with the acquisition, SEQENS entered a combination with Wavelength Pharmaceuticals, an existing SK Capital portfolio company which is also a global manufacturer and developer of active pharmaceutical ingredients. Additionally, prior to the closing, SEQENS divested certain non-core
Family office Schweizer Kapital and Kinstone Capital Partners have jointly founded a new venture capital company Kingstone Schweizer Ventures (KSV).
The investment goal is to fund ‘cutting-edge’ strategies within the impact investment universe that are particularly distinguished by their pioneering spirit and disruptive approaches.
Kingstone Schweizer Ventures plans to take a holistic investment approach that is designed to have the highest potential for impact.
RSM UK has advised on over 240 deals this year, with a combined value of GBP4.1 billion across the UK – showcasing a record year for the corporate finance practice and a 37 per cent increase in value over the prior year.
Of these deals, 136 transactions involved private equity (PE), growth of 79 per cent on the prior year as mid-market PE firms had their busiest year on record. The 136 transactions had a combined deal value of over GBP3 billion and were completed with 65 different PE firms, 59 per cent more than the prior year.
RSM UK’s
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
